CD8+ cytotoxic T cells, also known as cytotoxic T cells (CTL), are vital in the immune response against cancer [1] and closely related to a good clinical prognosis in many tumor types, including ovarian, colon, breast, and pancreatic cancer [2–6]. This evidence concerns the gene CD8A and neoplasm.